Limoneira (NASDAQ:LMNR - Get Free Report) is projected to post its quarterly earnings results after the market closes on Wednesday, March 12th. Analysts expect Limoneira to post earnings of ($0.17) per share and revenue of $40.70 million for the quarter. Parties interested in participating in the company's conference call can do so using this link.
Limoneira Trading Up 0.1 %
Shares of LMNR traded up $0.02 during mid-day trading on Friday, hitting $22.04. 40,167 shares of the company's stock traded hands, compared to its average volume of 50,866. The business's 50-day moving average price is $23.34 and its 200-day moving average price is $25.15. Limoneira has a 1 year low of $17.77 and a 1 year high of $29.22. The firm has a market capitalization of $398.55 million, a P/E ratio of 58.00 and a beta of 0.52. The company has a quick ratio of 0.69, a current ratio of 0.74 and a debt-to-equity ratio of 0.21.
Limoneira Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Monday, December 30th were given a $0.075 dividend. This represents a $0.30 annualized dividend and a dividend yield of 1.36%. The ex-dividend date was Monday, December 30th. Limoneira's dividend payout ratio is currently 78.95%.
Analyst Ratings Changes
Separately, StockNews.com cut Limoneira from a "hold" rating to a "sell" rating in a research report on Tuesday, February 4th.
View Our Latest Research Report on LMNR
About Limoneira
(
Get Free Report)
Limoneira Company operates as an agribusiness and real estate development company in the United States and internationally. The company operates through three divisions: Agribusiness, Rental Operations, and Real Estate Development. It grows, processes, packs, markets, and sells lemons. The company also grows avocado, oranges, and specialty citrus and other crops, including Moro blood oranges, Cara Cara oranges, Valencia oranges, Minneola tangelos, Star Ruby grapefruit, pummelos, and wine grapes.
Recommended Stories
Before you consider Limoneira, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Limoneira wasn't on the list.
While Limoneira currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
